Evidence map›Paper›PMID 19562332›Full record

ArticleEuropean biophysics journal : EBJ2010

Lambda exonuclease digestion of CGG trinucleotide repeats.

R S Conroy, A P Koretsky, J Moreland

Abstract read
In one paragraph

Article in European biophysics journal : EBJ, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Potential Applications of Thermophilic Bacteriophages in One Health.International journal of molecular sciences · 2023
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Detection of quadruplex DNA by gold nanoparticles.Journal of analytical methods in chemistry · 2012
    Article
  11. Enzyme-modulated DNA translocation through a nanopore.Journal of the American Chemical Society · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

R S ConroyLaboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, 20892, USA. conroyri@mail.nih.gov
A P Koretsky
J Moreland
National Institute of Neurological Disorders and Stroke · USNational Institute of Standards · EGNational Institute of Standards and Technology · US

Funding

MRI contrast for molecular and cellular imaging of the brainZIANS003047 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI KORETSKY, ALAN · 2009 to 2025
$29.3M
MRI contrast for molecular and cellular imaging of the brainZ01NS003047 · NINDS · NEUROLOGICAL DISORDERS AND STROKE · PI KORETSKY, ALAN · 2007 to 2008
$5.0M
Intramural NIH HHS Z01 NS003047
6 · The paper itself

Abstract

Fragile X syndrome and other trinucleotide diseases are characterized by an elongation of a repeating DNA triplet. The ensemble-averaged lambda exonuclease digestion rate of different substrates, including one with an elongated FMR1 gene containing 120 CGG repeats, was measured using absorption and fluorescence spectroscopy. By use of magnetic tweezers sequence-dependent digestion rates and pausing was measured for individual lambda exonucleases. Within the triplet repeats a lower average and narrower distribution of rates and a higher frequency of pausing was observed.

Indexed as

Trinucleotide RepeatsAbsorptionBacteriophage phi X 174ExonucleasesFluorescenceFragile X Messenger Ribonucleoprotein 1Spectrometry, FluorescenceTemperatureTime FactorsExonucleasesFragile X Messenger Ribonucleoprotein 1

Identifiers

PMID19562332
PMCPMC3197802
OpenAlexW2055997343

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.